1. Home
  2. GABC vs SPRY Comparison

GABC vs SPRY Comparison

Compare GABC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GABC
  • SPRY
  • Stock Information
  • Founded
  • GABC 1910
  • SPRY 2015
  • Country
  • GABC United States
  • SPRY United States
  • Employees
  • GABC N/A
  • SPRY N/A
  • Industry
  • GABC Major Banks
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • GABC Finance
  • SPRY Health Care
  • Exchange
  • GABC Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • GABC 1.6B
  • SPRY 1.8B
  • IPO Year
  • GABC N/A
  • SPRY N/A
  • Fundamental
  • Price
  • GABC $38.91
  • SPRY $10.37
  • Analyst Decision
  • GABC Hold
  • SPRY Strong Buy
  • Analyst Count
  • GABC 3
  • SPRY 5
  • Target Price
  • GABC $45.33
  • SPRY $31.00
  • AVG Volume (30 Days)
  • GABC 117.5K
  • SPRY 2.8M
  • Earning Date
  • GABC 10-27-2025
  • SPRY 11-12-2025
  • Dividend Yield
  • GABC 2.94%
  • SPRY N/A
  • EPS Growth
  • GABC N/A
  • SPRY N/A
  • EPS
  • GABC 2.62
  • SPRY N/A
  • Revenue
  • GABC $281,091,000.00
  • SPRY $112,339,000.00
  • Revenue This Year
  • GABC $46.34
  • SPRY N/A
  • Revenue Next Year
  • GABC $6.11
  • SPRY $188.92
  • P/E Ratio
  • GABC $15.07
  • SPRY N/A
  • Revenue Growth
  • GABC 13.87
  • SPRY 22367.80
  • 52 Week Low
  • GABC $32.75
  • SPRY $9.34
  • 52 Week High
  • GABC $47.08
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • GABC 39.57
  • SPRY 42.23
  • Support Level
  • GABC $38.87
  • SPRY $9.72
  • Resistance Level
  • GABC $39.85
  • SPRY $11.03
  • Average True Range (ATR)
  • GABC 0.71
  • SPRY 0.56
  • MACD
  • GABC -0.17
  • SPRY 0.27
  • Stochastic Oscillator
  • GABC 15.02
  • SPRY 57.23

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: